GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
KLF16
|
ENSG00000129911.4 | Kruppel like factor 16 |
SP2
|
ENSG00000167182.11 | Sp2 transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SP2 | hg19_v2_chr17_+_45973516_45973618 | 0.21 | 1.4e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_4135693 | 55.70 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr6_-_4135825 | 55.68 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr22_-_43583079 | 51.25 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
chr16_+_29817841 | 43.39 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr14_+_105219437 | 36.71 |
ENST00000329967.6
ENST00000347067.5 ENST00000553810.1 |
SIVA1
|
SIVA1, apoptosis-inducing factor |
chr19_-_55919087 | 33.45 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
chr11_+_1968508 | 33.42 |
ENST00000397298.3
ENST00000381519.1 ENST00000397297.3 ENST00000381514.3 ENST00000397294.3 |
MRPL23
|
mitochondrial ribosomal protein L23 |
chr2_-_215674374 | 32.07 |
ENST00000449967.2
ENST00000421162.1 ENST00000260947.4 |
BARD1
|
BRCA1 associated RING domain 1 |
chr7_+_26241310 | 31.88 |
ENST00000396386.2
|
CBX3
|
chromobox homolog 3 |
chr7_+_26241325 | 31.27 |
ENST00000456948.1
ENST00000409747.1 |
CBX3
|
chromobox homolog 3 |
chr19_+_54695098 | 31.13 |
ENST00000396388.2
|
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
chr19_+_54694119 | 30.84 |
ENST00000456872.1
ENST00000302937.4 ENST00000429671.2 |
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
chr15_+_80445113 | 30.43 |
ENST00000407106.1
ENST00000261755.5 |
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
chr20_+_32581452 | 29.83 |
ENST00000375114.3
ENST00000448364.1 |
RALY
|
RALY heterogeneous nuclear ribonucleoprotein |
chr2_-_10588630 | 29.53 |
ENST00000234111.4
|
ODC1
|
ornithine decarboxylase 1 |
chr11_-_64014379 | 29.37 |
ENST00000309318.3
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr11_-_34937858 | 29.07 |
ENST00000278359.5
|
APIP
|
APAF1 interacting protein |
chr3_+_155588375 | 28.94 |
ENST00000295920.7
|
GMPS
|
guanine monphosphate synthase |
chr4_-_174256276 | 28.61 |
ENST00000296503.5
|
HMGB2
|
high mobility group box 2 |
chr21_-_40720974 | 28.46 |
ENST00000380748.1
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
chr19_-_55658650 | 28.37 |
ENST00000589226.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr9_+_131452239 | 27.87 |
ENST00000372688.4
ENST00000372686.5 |
SET
|
SET nuclear oncogene |
chr20_+_32581525 | 27.21 |
ENST00000246194.3
ENST00000413297.1 |
RALY
|
RALY heterogeneous nuclear ribonucleoprotein |
chr3_+_160117418 | 27.11 |
ENST00000465903.1
ENST00000485645.1 ENST00000360111.2 ENST00000472991.1 ENST00000467468.1 ENST00000469762.1 ENST00000489573.1 ENST00000462787.1 ENST00000490207.1 ENST00000485867.1 |
SMC4
|
structural maintenance of chromosomes 4 |
chr21_-_40720995 | 26.88 |
ENST00000380749.5
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
chr4_+_57301896 | 26.32 |
ENST00000514888.1
ENST00000264221.2 ENST00000505164.1 |
PAICS
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
chr3_+_49711777 | 26.28 |
ENST00000442186.1
ENST00000438011.1 ENST00000457042.1 |
APEH
|
acylaminoacyl-peptide hydrolase |
chr12_+_69979113 | 25.53 |
ENST00000299300.6
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr16_+_29817399 | 25.45 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr18_+_3449821 | 25.41 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
chr6_+_24775153 | 25.36 |
ENST00000356509.3
ENST00000230056.3 |
GMNN
|
geminin, DNA replication inhibitor |
chr1_-_54411240 | 25.32 |
ENST00000371378.2
|
HSPB11
|
heat shock protein family B (small), member 11 |
chr12_-_109125285 | 25.23 |
ENST00000552871.1
ENST00000261401.3 |
CORO1C
|
coronin, actin binding protein, 1C |
chr14_-_21566731 | 25.08 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
chr18_+_3449695 | 25.04 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr15_+_80445232 | 24.96 |
ENST00000561421.1
|
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
chrX_-_152989798 | 24.93 |
ENST00000441714.1
ENST00000442093.1 ENST00000429550.1 ENST00000345046.6 |
BCAP31
|
B-cell receptor-associated protein 31 |
chr19_-_40971667 | 24.84 |
ENST00000263368.4
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr19_-_291365 | 24.64 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr6_+_3000057 | 24.23 |
ENST00000397717.2
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2 |
chr6_-_86352982 | 24.19 |
ENST00000369622.3
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
chr5_+_172385732 | 24.10 |
ENST00000519974.1
ENST00000521476.1 |
RPL26L1
|
ribosomal protein L26-like 1 |
chr21_-_38445470 | 24.03 |
ENST00000399098.1
|
PIGP
|
phosphatidylinositol glycan anchor biosynthesis, class P |
chr16_-_8962853 | 23.26 |
ENST00000565287.1
ENST00000311052.5 |
CARHSP1
|
calcium regulated heat stable protein 1, 24kDa |
chr19_-_40971643 | 23.22 |
ENST00000595483.1
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr4_+_99916765 | 22.95 |
ENST00000296411.6
|
METAP1
|
methionyl aminopeptidase 1 |
chr1_-_43638168 | 22.94 |
ENST00000431635.2
|
EBNA1BP2
|
EBNA1 binding protein 2 |
chr1_-_54411255 | 22.92 |
ENST00000371377.3
|
HSPB11
|
heat shock protein family B (small), member 11 |
chr14_-_105487381 | 22.64 |
ENST00000392590.3
ENST00000336219.3 |
CDCA4
|
cell division cycle associated 4 |
chr22_-_19165917 | 22.38 |
ENST00000451283.1
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
chr19_-_55658687 | 22.17 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr6_-_8102714 | 22.09 |
ENST00000502429.1
ENST00000429723.2 ENST00000507463.1 ENST00000379715.5 |
EEF1E1
|
eukaryotic translation elongation factor 1 epsilon 1 |
chr21_-_40555393 | 21.91 |
ENST00000380900.2
|
PSMG1
|
proteasome (prosome, macropain) assembly chaperone 1 |
chr19_-_42806723 | 21.81 |
ENST00000262890.3
|
PAFAH1B3
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) |
chr20_+_55926274 | 21.74 |
ENST00000371242.2
ENST00000527947.1 |
RAE1
|
ribonucleic acid export 1 |
chr2_-_174828892 | 21.73 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
chr7_+_26240776 | 21.70 |
ENST00000337620.4
|
CBX3
|
chromobox homolog 3 |
chr11_-_46142948 | 21.68 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
chr6_+_30689350 | 21.66 |
ENST00000330914.3
|
TUBB
|
tubulin, beta class I |
chr18_+_11981427 | 21.53 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr14_+_24605389 | 21.43 |
ENST00000382708.3
ENST00000561435.1 |
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr12_+_53342625 | 21.41 |
ENST00000388837.2
ENST00000550600.1 ENST00000388835.3 |
KRT18
|
keratin 18 |
chr6_+_34204642 | 21.34 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
chr13_+_28195988 | 21.32 |
ENST00000399697.3
ENST00000399696.1 |
POLR1D
|
polymerase (RNA) I polypeptide D, 16kDa |
chr20_+_62371206 | 21.18 |
ENST00000266077.2
|
SLC2A4RG
|
SLC2A4 regulator |
chr12_+_69979210 | 20.98 |
ENST00000544368.2
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr19_-_42806444 | 20.91 |
ENST00000594989.1
|
PAFAH1B3
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) |
chr8_+_26149007 | 20.64 |
ENST00000380737.3
ENST00000524169.1 |
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
chr7_-_148580563 | 20.56 |
ENST00000476773.1
|
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
chr19_+_30302805 | 20.52 |
ENST00000262643.3
ENST00000575243.1 ENST00000357943.5 |
CCNE1
|
cyclin E1 |
chr6_+_30689401 | 20.47 |
ENST00000396389.1
ENST00000396384.1 |
TUBB
|
tubulin, beta class I |
chr9_-_111775772 | 20.46 |
ENST00000325580.6
ENST00000374593.4 ENST00000374595.4 ENST00000325551.4 |
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1 |
chr1_-_26232522 | 20.42 |
ENST00000399728.1
|
STMN1
|
stathmin 1 |
chr1_+_54411995 | 20.21 |
ENST00000319223.4
ENST00000444987.1 |
LRRC42
|
leucine rich repeat containing 42 |
chr9_+_91926103 | 20.09 |
ENST00000314355.6
|
CKS2
|
CDC28 protein kinase regulatory subunit 2 |
chr19_+_10362577 | 20.00 |
ENST00000592514.1
ENST00000307422.5 ENST00000253099.6 ENST00000590150.1 ENST00000590669.1 |
MRPL4
|
mitochondrial ribosomal protein L4 |
chr20_-_49547731 | 19.75 |
ENST00000396029.3
|
ADNP
|
activity-dependent neuroprotector homeobox |
chr6_+_3000218 | 19.74 |
ENST00000380441.1
ENST00000380455.4 ENST00000380454.4 |
NQO2
|
NAD(P)H dehydrogenase, quinone 2 |
chrX_+_153991025 | 19.65 |
ENST00000369550.5
|
DKC1
|
dyskeratosis congenita 1, dyskerin |
chr19_+_35645817 | 19.62 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr2_+_48010312 | 19.62 |
ENST00000540021.1
|
MSH6
|
mutS homolog 6 |
chr10_-_5931794 | 19.30 |
ENST00000380092.4
ENST00000380094.5 ENST00000191063.8 |
ANKRD16
|
ankyrin repeat domain 16 |
chr18_+_12948000 | 19.28 |
ENST00000585730.1
ENST00000399892.2 ENST00000589446.1 ENST00000587761.1 |
SEH1L
|
SEH1-like (S. cerevisiae) |
chr4_-_174255536 | 19.07 |
ENST00000446922.2
|
HMGB2
|
high mobility group box 2 |
chr14_-_24615805 | 19.04 |
ENST00000560410.1
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr19_+_59055814 | 18.98 |
ENST00000594806.1
ENST00000253024.5 ENST00000341753.6 |
TRIM28
|
tripartite motif containing 28 |
chr16_+_2521500 | 18.95 |
ENST00000293973.1
|
NTN3
|
netrin 3 |
chr19_-_59010565 | 18.93 |
ENST00000594786.1
|
SLC27A5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr6_+_3000195 | 18.78 |
ENST00000338130.2
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2 |
chr2_+_172778952 | 18.75 |
ENST00000392584.1
ENST00000264108.4 |
HAT1
|
histone acetyltransferase 1 |
chr3_+_160117087 | 18.67 |
ENST00000357388.3
|
SMC4
|
structural maintenance of chromosomes 4 |
chr20_-_5107180 | 18.48 |
ENST00000379160.3
|
PCNA
|
proliferating cell nuclear antigen |
chr1_+_43148625 | 18.44 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
chrX_+_118602363 | 18.42 |
ENST00000317881.8
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
chr11_-_34938039 | 18.41 |
ENST00000395787.3
|
APIP
|
APAF1 interacting protein |
chr20_+_34129770 | 18.39 |
ENST00000348547.2
ENST00000357394.4 ENST00000447986.1 ENST00000279052.6 ENST00000416206.1 ENST00000411577.1 ENST00000413587.1 |
ERGIC3
|
ERGIC and golgi 3 |
chr1_+_43824577 | 18.36 |
ENST00000310955.6
|
CDC20
|
cell division cycle 20 |
chr16_-_87903079 | 18.17 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
chr11_+_65686952 | 18.16 |
ENST00000527119.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr17_+_7155343 | 18.15 |
ENST00000573513.1
ENST00000354429.2 ENST00000574255.1 ENST00000396627.2 ENST00000356683.2 |
ELP5
|
elongator acetyltransferase complex subunit 5 |
chr21_-_38445443 | 18.14 |
ENST00000360525.4
|
PIGP
|
phosphatidylinositol glycan anchor biosynthesis, class P |
chr13_+_28194873 | 17.82 |
ENST00000302979.3
|
POLR1D
|
polymerase (RNA) I polypeptide D, 16kDa |
chr16_-_58163299 | 17.78 |
ENST00000262498.3
|
C16orf80
|
chromosome 16 open reading frame 80 |
chr17_-_15466742 | 17.68 |
ENST00000584811.1
ENST00000419890.2 |
TVP23C
|
trans-golgi network vesicle protein 23 homolog C (S. cerevisiae) |
chr12_-_48099754 | 17.65 |
ENST00000380650.4
|
RPAP3
|
RNA polymerase II associated protein 3 |
chr7_-_105162652 | 17.63 |
ENST00000356362.2
ENST00000469408.1 |
PUS7
|
pseudouridylate synthase 7 homolog (S. cerevisiae) |
chr19_+_6361795 | 17.53 |
ENST00000596149.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
chr1_+_226250379 | 17.49 |
ENST00000366815.3
ENST00000366814.3 |
H3F3A
|
H3 histone, family 3A |
chr11_+_64009072 | 17.48 |
ENST00000535135.1
ENST00000394540.3 |
FKBP2
|
FK506 binding protein 2, 13kDa |
chr15_+_57210961 | 17.44 |
ENST00000557843.1
|
TCF12
|
transcription factor 12 |
chr19_-_55791540 | 17.22 |
ENST00000433386.2
|
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
chr4_+_57302297 | 17.21 |
ENST00000399688.3
ENST00000512576.1 |
PAICS
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
chr20_+_42295745 | 17.20 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
chr22_-_19166343 | 17.17 |
ENST00000215882.5
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
chr19_+_50180317 | 17.17 |
ENST00000534465.1
|
PRMT1
|
protein arginine methyltransferase 1 |
chr19_-_16770915 | 17.10 |
ENST00000593459.1
ENST00000358726.6 ENST00000597711.1 ENST00000487416.2 |
CTC-429P9.4
SMIM7
|
Small integral membrane protein 7; Uncharacterized protein small integral membrane protein 7 |
chr4_+_184426147 | 17.10 |
ENST00000302327.3
|
ING2
|
inhibitor of growth family, member 2 |
chr11_+_65686802 | 17.10 |
ENST00000376991.2
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr5_+_68462837 | 17.10 |
ENST00000256442.5
|
CCNB1
|
cyclin B1 |
chr5_+_68462944 | 17.07 |
ENST00000506572.1
|
CCNB1
|
cyclin B1 |
chr14_+_24605361 | 17.00 |
ENST00000206451.6
ENST00000559123.1 |
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr10_-_43904608 | 16.99 |
ENST00000337970.3
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F |
chr9_-_113018746 | 16.98 |
ENST00000374515.5
|
TXN
|
thioredoxin |
chr19_+_6361754 | 16.93 |
ENST00000597326.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
chr3_+_180630444 | 16.81 |
ENST00000491062.1
ENST00000468861.1 ENST00000445140.2 ENST00000484958.1 |
FXR1
|
fragile X mental retardation, autosomal homolog 1 |
chr12_+_109535373 | 16.77 |
ENST00000242576.2
|
UNG
|
uracil-DNA glycosylase |
chr7_-_154794763 | 16.66 |
ENST00000404141.1
|
PAXIP1
|
PAX interacting (with transcription-activation domain) protein 1 |
chr17_-_15466850 | 16.61 |
ENST00000438826.3
ENST00000225576.3 ENST00000519970.1 ENST00000518321.1 ENST00000428082.2 ENST00000522212.2 |
TVP23C
TVP23C-CDRT4
|
trans-golgi network vesicle protein 23 homolog C (S. cerevisiae) TVP23C-CDRT4 readthrough |
chr6_-_18265050 | 16.55 |
ENST00000397239.3
|
DEK
|
DEK oncogene |
chrX_-_153775426 | 16.42 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
chr15_+_52311398 | 16.42 |
ENST00000261845.5
|
MAPK6
|
mitogen-activated protein kinase 6 |
chr19_-_1652575 | 16.41 |
ENST00000587235.1
ENST00000262965.5 |
TCF3
|
transcription factor 3 |
chr11_-_64013288 | 16.33 |
ENST00000542235.1
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr1_-_3816779 | 16.27 |
ENST00000361605.3
|
C1orf174
|
chromosome 1 open reading frame 174 |
chr17_-_73149921 | 16.23 |
ENST00000481647.1
ENST00000470924.1 |
HN1
|
hematological and neurological expressed 1 |
chr1_-_193029192 | 16.21 |
ENST00000417752.1
ENST00000367452.4 |
UCHL5
|
ubiquitin carboxyl-terminal hydrolase L5 |
chr12_+_69979446 | 16.19 |
ENST00000543146.2
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr20_+_57556263 | 16.15 |
ENST00000602795.1
ENST00000344018.3 |
NELFCD
|
negative elongation factor complex member C/D |
chr3_+_49711391 | 16.00 |
ENST00000296456.5
ENST00000449966.1 |
APEH
|
acylaminoacyl-peptide hydrolase |
chr10_+_114709999 | 16.00 |
ENST00000355995.4
ENST00000545257.1 ENST00000543371.1 ENST00000536810.1 ENST00000355717.4 ENST00000538897.1 ENST00000534894.1 |
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box) |
chr19_+_49496782 | 15.99 |
ENST00000601968.1
ENST00000596837.1 |
RUVBL2
|
RuvB-like AAA ATPase 2 |
chr1_+_45205498 | 15.96 |
ENST00000372218.4
|
KIF2C
|
kinesin family member 2C |
chr1_+_46713357 | 15.93 |
ENST00000442598.1
|
RAD54L
|
RAD54-like (S. cerevisiae) |
chr13_+_53029564 | 15.92 |
ENST00000468284.1
ENST00000378034.3 ENST00000258607.5 ENST00000378037.5 |
CKAP2
|
cytoskeleton associated protein 2 |
chr12_+_2904102 | 15.90 |
ENST00000001008.4
|
FKBP4
|
FK506 binding protein 4, 59kDa |
chr5_-_79950775 | 15.79 |
ENST00000439211.2
|
DHFR
|
dihydrofolate reductase |
chr1_-_26232951 | 15.76 |
ENST00000426559.2
ENST00000455785.2 |
STMN1
|
stathmin 1 |
chr8_-_124428569 | 15.69 |
ENST00000521903.1
|
ATAD2
|
ATPase family, AAA domain containing 2 |
chr11_+_134201911 | 15.68 |
ENST00000389881.3
|
GLB1L2
|
galactosidase, beta 1-like 2 |
chr21_+_44394742 | 15.66 |
ENST00000432907.2
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
chr21_-_33651324 | 15.65 |
ENST00000290130.3
|
MIS18A
|
MIS18 kinetochore protein A |
chr20_-_52210368 | 15.63 |
ENST00000371471.2
|
ZNF217
|
zinc finger protein 217 |
chr2_-_10952832 | 15.55 |
ENST00000540494.1
|
PDIA6
|
protein disulfide isomerase family A, member 6 |
chrX_-_152989531 | 15.55 |
ENST00000458587.2
ENST00000416815.1 |
BCAP31
|
B-cell receptor-associated protein 31 |
chr1_+_45205478 | 15.52 |
ENST00000452259.1
ENST00000372224.4 |
KIF2C
|
kinesin family member 2C |
chr17_+_80709932 | 15.51 |
ENST00000355528.4
ENST00000397466.2 ENST00000539345.2 |
TBCD
|
tubulin folding cofactor D |
chr2_-_153574480 | 15.50 |
ENST00000410080.1
|
PRPF40A
|
PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) |
chr1_-_24126892 | 15.47 |
ENST00000374497.3
ENST00000425913.1 |
GALE
|
UDP-galactose-4-epimerase |
chr15_-_66679019 | 15.42 |
ENST00000568216.1
ENST00000562124.1 ENST00000570251.1 |
TIPIN
|
TIMELESS interacting protein |
chr2_+_10262442 | 15.38 |
ENST00000360566.2
|
RRM2
|
ribonucleotide reductase M2 |
chr20_-_33872548 | 15.37 |
ENST00000374443.3
|
EIF6
|
eukaryotic translation initiation factor 6 |
chr17_-_76183111 | 15.37 |
ENST00000405273.1
ENST00000590862.1 ENST00000590430.1 ENST00000586613.1 |
TK1
|
thymidine kinase 1, soluble |
chr19_+_10982189 | 15.27 |
ENST00000327064.4
ENST00000588947.1 |
CARM1
|
coactivator-associated arginine methyltransferase 1 |
chr20_-_33872518 | 15.23 |
ENST00000374436.3
|
EIF6
|
eukaryotic translation initiation factor 6 |
chr10_-_43904235 | 15.18 |
ENST00000356053.3
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F |
chrX_-_151903101 | 15.18 |
ENST00000393900.3
|
MAGEA12
|
melanoma antigen family A, 12 |
chr11_+_34938119 | 15.15 |
ENST00000227868.4
ENST00000430469.2 ENST00000533262.1 |
PDHX
|
pyruvate dehydrogenase complex, component X |
chr18_+_12947981 | 15.11 |
ENST00000262124.11
|
SEH1L
|
SEH1-like (S. cerevisiae) |
chr19_-_48673580 | 15.11 |
ENST00000427526.2
|
LIG1
|
ligase I, DNA, ATP-dependent |
chrX_-_16888448 | 15.07 |
ENST00000468092.1
ENST00000404022.1 ENST00000380087.2 |
RBBP7
|
retinoblastoma binding protein 7 |
chr7_-_99698338 | 15.05 |
ENST00000354230.3
ENST00000425308.1 |
MCM7
|
minichromosome maintenance complex component 7 |
chr19_-_17356697 | 15.04 |
ENST00000291442.3
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6 |
chr11_+_65687158 | 15.03 |
ENST00000532933.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr14_+_105886150 | 15.00 |
ENST00000331320.7
ENST00000406191.1 |
MTA1
|
metastasis associated 1 |
chr19_-_55791431 | 14.99 |
ENST00000593263.1
ENST00000376343.3 |
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
chr19_-_39342962 | 14.98 |
ENST00000600873.1
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L |
chr11_+_64808368 | 14.98 |
ENST00000531072.1
ENST00000398846.1 |
SAC3D1
|
SAC3 domain containing 1 |
chr19_+_35645618 | 14.97 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr2_+_122494676 | 14.96 |
ENST00000455432.1
|
TSN
|
translin |
chr1_+_46713404 | 14.94 |
ENST00000371975.4
ENST00000469835.1 |
RAD54L
|
RAD54-like (S. cerevisiae) |
chr11_+_134201768 | 14.94 |
ENST00000535456.2
ENST00000339772.7 |
GLB1L2
|
galactosidase, beta 1-like 2 |
chr20_+_388935 | 14.87 |
ENST00000382181.2
ENST00000400247.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr19_-_42806842 | 14.83 |
ENST00000596265.1
|
PAFAH1B3
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) |
chr11_-_57103327 | 14.82 |
ENST00000529002.1
ENST00000278412.2 |
SSRP1
|
structure specific recognition protein 1 |
chr17_-_47492164 | 14.78 |
ENST00000512041.2
ENST00000446735.1 ENST00000504124.1 |
PHB
|
prohibitin |
chr7_+_75932863 | 14.75 |
ENST00000429938.1
|
HSPB1
|
heat shock 27kDa protein 1 |
chr19_+_50180409 | 14.75 |
ENST00000391851.4
|
PRMT1
|
protein arginine methyltransferase 1 |
chr8_-_17104356 | 14.72 |
ENST00000361272.4
ENST00000523917.1 |
CNOT7
|
CCR4-NOT transcription complex, subunit 7 |
chr16_-_88878305 | 14.72 |
ENST00000569616.1
ENST00000563655.1 ENST00000567713.1 ENST00000426324.2 ENST00000378364.3 |
APRT
|
adenine phosphoribosyltransferase |
chrX_+_151867214 | 14.64 |
ENST00000329342.5
ENST00000412733.1 ENST00000457643.1 |
MAGEA6
|
melanoma antigen family A, 6 |
chr3_+_180630090 | 14.59 |
ENST00000357559.4
ENST00000305586.7 |
FXR1
|
fragile X mental retardation, autosomal homolog 1 |
chr19_+_12917364 | 14.57 |
ENST00000221486.4
|
RNASEH2A
|
ribonuclease H2, subunit A |
chr10_+_75910960 | 14.48 |
ENST00000539909.1
ENST00000286621.2 |
ADK
|
adenosine kinase |
chr5_-_79950371 | 14.47 |
ENST00000511032.1
ENST00000504396.1 ENST00000505337.1 |
DHFR
|
dihydrofolate reductase |
chr1_-_17380630 | 14.45 |
ENST00000375499.3
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
chr1_+_10459111 | 14.40 |
ENST00000541529.1
ENST00000270776.8 ENST00000483936.1 ENST00000538557.1 |
PGD
|
phosphogluconate dehydrogenase |
chr5_+_68463043 | 14.40 |
ENST00000508407.1
ENST00000505500.1 |
CCNB1
|
cyclin B1 |
chr6_+_44191290 | 14.37 |
ENST00000371755.3
ENST00000371740.5 ENST00000371731.1 ENST00000393841.1 |
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
chr11_+_65686728 | 14.32 |
ENST00000312515.2
ENST00000525501.1 |
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr2_+_48010221 | 14.20 |
ENST00000234420.5
|
MSH6
|
mutS homolog 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.9 | 62.7 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
20.7 | 62.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
16.5 | 66.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
13.0 | 52.0 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
12.8 | 38.3 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
11.6 | 46.6 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
11.5 | 34.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
11.1 | 33.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
10.8 | 43.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
10.7 | 21.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
10.5 | 73.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
10.3 | 51.4 | GO:0015862 | uridine transport(GO:0015862) |
10.2 | 10.2 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
9.9 | 39.6 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
9.5 | 114.4 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
9.0 | 36.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
9.0 | 26.9 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
8.9 | 44.6 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
8.8 | 70.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
8.8 | 35.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
8.7 | 34.9 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
8.5 | 51.0 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
8.5 | 42.5 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
8.5 | 8.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
8.5 | 8.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
8.4 | 42.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
8.3 | 41.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
8.2 | 41.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
8.2 | 16.4 | GO:0044209 | AMP salvage(GO:0044209) |
8.0 | 56.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
8.0 | 23.9 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
7.9 | 47.6 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
7.9 | 15.9 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
7.9 | 23.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
7.9 | 23.6 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
7.8 | 7.8 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
7.8 | 23.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
7.7 | 46.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
7.6 | 68.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
7.2 | 7.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
7.1 | 28.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
7.0 | 28.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
7.0 | 48.8 | GO:0070269 | pyroptosis(GO:0070269) |
6.9 | 41.6 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
6.8 | 27.3 | GO:0002424 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
6.7 | 33.6 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
6.7 | 67.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
6.6 | 66.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
6.6 | 26.3 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
6.5 | 19.6 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
6.4 | 19.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
6.4 | 19.2 | GO:0042351 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
6.3 | 25.3 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
6.3 | 37.9 | GO:0030421 | defecation(GO:0030421) |
6.2 | 18.5 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
6.2 | 18.5 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
6.0 | 54.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
6.0 | 29.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
5.9 | 5.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
5.8 | 57.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
5.7 | 57.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
5.7 | 79.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
5.7 | 5.7 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
5.6 | 16.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
5.6 | 28.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
5.6 | 22.4 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
5.4 | 21.7 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
5.4 | 10.9 | GO:1901656 | glycoside transport(GO:1901656) |
5.4 | 32.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
5.4 | 43.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
5.4 | 26.8 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
5.3 | 32.0 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
5.3 | 53.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
5.3 | 16.0 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
5.2 | 20.9 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
5.2 | 26.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
5.2 | 5.2 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
5.2 | 15.6 | GO:0002188 | translation reinitiation(GO:0002188) |
5.2 | 15.5 | GO:0009177 | pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
5.1 | 25.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
5.1 | 15.3 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
5.0 | 15.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
5.0 | 5.0 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
5.0 | 14.9 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
4.9 | 34.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
4.9 | 63.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
4.9 | 14.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
4.8 | 28.8 | GO:0015853 | adenine transport(GO:0015853) |
4.8 | 14.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
4.8 | 24.0 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
4.8 | 24.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
4.7 | 18.8 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
4.6 | 13.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
4.6 | 46.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
4.6 | 23.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
4.6 | 41.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
4.6 | 32.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
4.6 | 18.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
4.5 | 31.8 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
4.5 | 94.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
4.5 | 13.5 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
4.5 | 4.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
4.5 | 13.5 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
4.5 | 13.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
4.5 | 4.5 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) positive regulation of somatic stem cell population maintenance(GO:1904674) |
4.5 | 13.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
4.3 | 21.5 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
4.3 | 8.6 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
4.3 | 21.3 | GO:1903412 | response to bile acid(GO:1903412) |
4.3 | 12.8 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
4.2 | 12.7 | GO:0071422 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
4.2 | 25.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
4.2 | 12.7 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
4.1 | 12.4 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
4.1 | 20.7 | GO:0061198 | fungiform papilla formation(GO:0061198) |
4.1 | 20.7 | GO:0051182 | coenzyme transport(GO:0051182) |
4.1 | 111.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
4.1 | 8.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
4.1 | 65.3 | GO:0043248 | proteasome assembly(GO:0043248) |
4.1 | 12.2 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
4.1 | 20.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
4.1 | 12.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
4.0 | 36.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
4.0 | 20.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
4.0 | 4.0 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
3.9 | 11.8 | GO:1902822 | regulation of late endosome to lysosome transport(GO:1902822) |
3.9 | 19.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.9 | 19.5 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
3.9 | 15.5 | GO:0048478 | replication fork protection(GO:0048478) |
3.9 | 27.1 | GO:1902915 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
3.9 | 27.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
3.8 | 11.5 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
3.8 | 11.5 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
3.8 | 38.0 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
3.8 | 11.4 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
3.8 | 15.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
3.8 | 18.8 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
3.7 | 11.2 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
3.7 | 3.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
3.7 | 22.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
3.7 | 54.8 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
3.6 | 14.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
3.6 | 21.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
3.6 | 46.9 | GO:0070986 | left/right axis specification(GO:0070986) |
3.6 | 14.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.6 | 21.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
3.5 | 7.0 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
3.5 | 94.8 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
3.5 | 3.5 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
3.5 | 14.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
3.5 | 27.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
3.5 | 10.4 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
3.5 | 6.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
3.5 | 20.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
3.4 | 10.3 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
3.4 | 249.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
3.4 | 10.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
3.4 | 10.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
3.4 | 20.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
3.4 | 3.4 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
3.4 | 23.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
3.3 | 26.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
3.3 | 23.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
3.3 | 13.1 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
3.3 | 16.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
3.3 | 3.3 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
3.3 | 9.8 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
3.2 | 6.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
3.2 | 16.2 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
3.2 | 19.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
3.2 | 19.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
3.2 | 19.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
3.2 | 41.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
3.1 | 22.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
3.1 | 15.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
3.1 | 62.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
3.1 | 78.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
3.1 | 9.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
3.1 | 49.7 | GO:0021670 | lateral ventricle development(GO:0021670) |
3.1 | 9.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
3.1 | 9.3 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
3.1 | 61.6 | GO:0006415 | translational termination(GO:0006415) |
3.1 | 9.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
3.1 | 3.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
3.1 | 24.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
3.1 | 3.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
3.0 | 15.2 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
3.0 | 15.2 | GO:0019640 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
3.0 | 3.0 | GO:0015698 | inorganic anion transport(GO:0015698) |
3.0 | 36.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
3.0 | 15.1 | GO:1902896 | terminal web assembly(GO:1902896) |
3.0 | 3.0 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
3.0 | 14.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
3.0 | 41.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
3.0 | 8.9 | GO:0006404 | RNA import into nucleus(GO:0006404) |
2.9 | 8.8 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
2.9 | 17.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
2.9 | 8.7 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
2.9 | 5.8 | GO:0006740 | NADPH regeneration(GO:0006740) |
2.9 | 66.6 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
2.9 | 23.1 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
2.9 | 23.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
2.9 | 11.5 | GO:0032218 | riboflavin transport(GO:0032218) |
2.9 | 100.8 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
2.9 | 8.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
2.8 | 11.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.8 | 2.8 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
2.8 | 11.3 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
2.8 | 31.0 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
2.8 | 36.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
2.8 | 8.4 | GO:0048382 | mesendoderm development(GO:0048382) |
2.8 | 5.6 | GO:0035822 | gene conversion(GO:0035822) |
2.8 | 19.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
2.8 | 8.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
2.8 | 19.4 | GO:1904044 | response to aldosterone(GO:1904044) |
2.8 | 2.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
2.7 | 16.5 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
2.7 | 11.0 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
2.7 | 40.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
2.7 | 2.7 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
2.7 | 13.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
2.7 | 5.4 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
2.7 | 2.7 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
2.7 | 2.7 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
2.7 | 2.7 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
2.7 | 18.8 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
2.7 | 2.7 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
2.7 | 8.0 | GO:0050894 | determination of affect(GO:0050894) |
2.7 | 2.7 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
2.6 | 7.9 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
2.6 | 7.9 | GO:1905214 | regulation of RNA binding(GO:1905214) |
2.6 | 5.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
2.6 | 220.7 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
2.6 | 7.8 | GO:1901355 | response to rapamycin(GO:1901355) |
2.6 | 5.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
2.6 | 51.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
2.6 | 10.3 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
2.6 | 7.7 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
2.6 | 18.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.6 | 12.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
2.5 | 17.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
2.5 | 17.6 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.5 | 5.0 | GO:0009136 | ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
2.5 | 7.5 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
2.5 | 7.5 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
2.5 | 14.9 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
2.5 | 9.9 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
2.5 | 64.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
2.5 | 19.8 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
2.5 | 184.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.4 | 7.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
2.4 | 7.3 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
2.4 | 38.9 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
2.4 | 7.3 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
2.4 | 9.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
2.4 | 33.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
2.4 | 7.2 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
2.4 | 21.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
2.4 | 37.7 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
2.3 | 4.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
2.3 | 14.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
2.3 | 107.9 | GO:0006363 | transcription elongation from RNA polymerase I promoter(GO:0006362) termination of RNA polymerase I transcription(GO:0006363) |
2.3 | 2.3 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
2.3 | 16.2 | GO:0046618 | drug export(GO:0046618) |
2.3 | 2.3 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
2.3 | 4.6 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
2.3 | 101.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
2.3 | 2.3 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
2.3 | 2.3 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
2.3 | 6.8 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
2.3 | 18.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.3 | 36.0 | GO:0045116 | protein neddylation(GO:0045116) |
2.2 | 9.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
2.2 | 6.7 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
2.2 | 17.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
2.2 | 28.9 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
2.2 | 13.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
2.2 | 6.7 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
2.2 | 35.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
2.2 | 24.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
2.2 | 4.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
2.2 | 70.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
2.2 | 6.6 | GO:0033341 | regulation of collagen binding(GO:0033341) |
2.2 | 13.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
2.2 | 13.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
2.2 | 4.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.2 | 8.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
2.2 | 2.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
2.2 | 13.1 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
2.2 | 17.5 | GO:0044351 | macropinocytosis(GO:0044351) |
2.2 | 8.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
2.2 | 4.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
2.2 | 21.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
2.2 | 4.3 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
2.2 | 6.5 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
2.1 | 6.4 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
2.1 | 12.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
2.1 | 6.3 | GO:0048627 | myoblast development(GO:0048627) |
2.1 | 10.6 | GO:0016240 | autophagosome docking(GO:0016240) |
2.1 | 2.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
2.1 | 20.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
2.1 | 8.3 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
2.1 | 6.2 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
2.1 | 16.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
2.1 | 4.1 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
2.1 | 6.2 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
2.1 | 8.2 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
2.1 | 8.2 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
2.1 | 20.5 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
2.0 | 6.1 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
2.0 | 8.2 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
2.0 | 6.1 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.0 | 18.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
2.0 | 14.1 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
2.0 | 10.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
2.0 | 18.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
2.0 | 2.0 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
2.0 | 2.0 | GO:0040031 | snRNA modification(GO:0040031) |
2.0 | 2.0 | GO:0060613 | fat pad development(GO:0060613) |
2.0 | 2.0 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
2.0 | 8.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
2.0 | 9.9 | GO:1900673 | olefin metabolic process(GO:1900673) |
2.0 | 7.9 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
2.0 | 11.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
2.0 | 9.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
2.0 | 9.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
2.0 | 13.7 | GO:0007144 | female meiosis I(GO:0007144) |
1.9 | 7.8 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.9 | 21.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.9 | 17.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
1.9 | 3.8 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
1.9 | 1.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.9 | 7.5 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
1.9 | 7.5 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.9 | 3.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.9 | 7.5 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.9 | 3.7 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.9 | 9.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.9 | 16.7 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
1.9 | 5.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.8 | 7.4 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
1.8 | 5.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
1.8 | 138.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
1.8 | 11.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.8 | 23.6 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
1.8 | 3.6 | GO:0060621 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
1.8 | 23.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.8 | 7.2 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
1.8 | 3.6 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
1.8 | 23.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
1.8 | 1.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
1.8 | 3.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.8 | 5.4 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
1.8 | 1.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.8 | 10.7 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
1.8 | 10.7 | GO:0044211 | CTP salvage(GO:0044211) |
1.8 | 16.0 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
1.8 | 19.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
1.8 | 8.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.8 | 5.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.8 | 44.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.8 | 5.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.8 | 1.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.8 | 7.0 | GO:0042262 | DNA protection(GO:0042262) |
1.8 | 1.8 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
1.8 | 5.3 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
1.7 | 10.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.7 | 15.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.7 | 8.6 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) farnesyl diphosphate metabolic process(GO:0045338) |
1.7 | 10.3 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
1.7 | 5.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
1.7 | 1.7 | GO:0043584 | nose development(GO:0043584) |
1.7 | 6.8 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
1.7 | 1.7 | GO:0000055 | ribosomal subunit export from nucleus(GO:0000054) ribosomal large subunit export from nucleus(GO:0000055) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
1.7 | 30.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.7 | 3.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
1.7 | 10.2 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.7 | 18.6 | GO:0006105 | succinate metabolic process(GO:0006105) |
1.7 | 6.8 | GO:2000491 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
1.7 | 1.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
1.7 | 1.7 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
1.7 | 6.7 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
1.7 | 1.7 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
1.7 | 13.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
1.7 | 31.8 | GO:0032392 | DNA geometric change(GO:0032392) |
1.7 | 53.6 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
1.7 | 1.7 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.7 | 5.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
1.7 | 6.7 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.7 | 11.7 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
1.7 | 1.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.7 | 51.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
1.6 | 13.2 | GO:0015791 | polyol transport(GO:0015791) |
1.6 | 13.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.6 | 4.9 | GO:0072718 | response to cisplatin(GO:0072718) |
1.6 | 19.7 | GO:0016180 | snRNA processing(GO:0016180) |
1.6 | 8.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
1.6 | 14.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.6 | 4.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.6 | 3.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
1.6 | 8.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
1.6 | 56.4 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
1.6 | 70.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.6 | 6.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.6 | 1.6 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
1.6 | 8.0 | GO:0030047 | actin modification(GO:0030047) |
1.6 | 24.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.6 | 1.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.6 | 4.8 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
1.6 | 3.2 | GO:0060066 | oviduct development(GO:0060066) |
1.6 | 4.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.6 | 9.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
1.6 | 21.8 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
1.6 | 3.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
1.5 | 1.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.5 | 4.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.5 | 4.6 | GO:0093001 | glycolytic process through glucose-1-phosphate(GO:0061622) glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
1.5 | 7.6 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
1.5 | 42.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
1.5 | 9.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.5 | 3.0 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
1.5 | 4.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
1.5 | 13.4 | GO:0090151 | protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
1.5 | 16.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.5 | 13.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.5 | 5.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.5 | 4.4 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.5 | 1.5 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
1.5 | 2.9 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
1.5 | 5.8 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.5 | 14.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
1.4 | 7.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.4 | 4.3 | GO:0051300 | spindle pole body duplication(GO:0030474) nuclear pore distribution(GO:0031081) spindle pole body organization(GO:0051300) nuclear pore localization(GO:0051664) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
1.4 | 2.9 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
1.4 | 2.9 | GO:0070541 | response to platinum ion(GO:0070541) |
1.4 | 28.7 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
1.4 | 1.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.4 | 4.3 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
1.4 | 12.8 | GO:0060426 | lung vasculature development(GO:0060426) |
1.4 | 8.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.4 | 4.2 | GO:1901253 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of intracellular transport of viral material(GO:1901253) |
1.4 | 8.5 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
1.4 | 1.4 | GO:0061205 | paramesonephric duct development(GO:0061205) |
1.4 | 4.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
1.4 | 4.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.4 | 1.4 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
1.4 | 4.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
1.4 | 14.0 | GO:0060056 | mammary gland involution(GO:0060056) |
1.4 | 40.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
1.4 | 9.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.4 | 1.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.4 | 4.2 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
1.4 | 13.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
1.4 | 8.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
1.4 | 17.9 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.4 | 26.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
1.4 | 4.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
1.4 | 6.9 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
1.4 | 1.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
1.4 | 10.8 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
1.3 | 8.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
1.3 | 4.0 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
1.3 | 9.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.3 | 1.3 | GO:0070295 | renal water absorption(GO:0070295) |
1.3 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
1.3 | 11.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.3 | 1.3 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
1.3 | 2.6 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
1.3 | 1.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.3 | 6.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.3 | 1.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
1.3 | 28.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.3 | 20.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.3 | 3.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.3 | 1.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
1.3 | 3.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.3 | 10.2 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
1.3 | 2.5 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
1.3 | 5.1 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
1.3 | 10.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.3 | 1.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.3 | 3.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.3 | 2.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.3 | 2.5 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.2 | 5.0 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
1.2 | 5.0 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.2 | 87.9 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
1.2 | 3.7 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
1.2 | 3.7 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.2 | 1.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.2 | 2.5 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
1.2 | 2.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
1.2 | 12.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.2 | 87.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.2 | 19.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
1.2 | 7.2 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
1.2 | 1.2 | GO:2000977 | comma-shaped body morphogenesis(GO:0072049) regulation of forebrain neuron differentiation(GO:2000977) |
1.2 | 1.2 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.2 | 7.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
1.2 | 2.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
1.2 | 4.7 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
1.2 | 26.7 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
1.2 | 69.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.2 | 7.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.2 | 1.2 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
1.2 | 5.8 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.2 | 6.9 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.1 | 6.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.1 | 1.1 | GO:0044818 | mitotic DNA replication checkpoint(GO:0033314) mitotic G2/M transition checkpoint(GO:0044818) |
1.1 | 13.7 | GO:0030261 | chromosome condensation(GO:0030261) |
1.1 | 1.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.1 | 21.5 | GO:0006825 | copper ion transport(GO:0006825) |
1.1 | 15.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.1 | 4.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.1 | 4.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
1.1 | 4.5 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
1.1 | 11.1 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
1.1 | 1.1 | GO:0060166 | olfactory pit development(GO:0060166) |
1.1 | 1.1 | GO:0035268 | protein mannosylation(GO:0035268) |
1.1 | 4.4 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
1.1 | 4.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.1 | 2.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
1.1 | 10.8 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
1.1 | 3.2 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
1.1 | 4.2 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
1.1 | 2.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.1 | 5.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
1.0 | 4.2 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
1.0 | 5.2 | GO:0010225 | response to UV-C(GO:0010225) |
1.0 | 13.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.0 | 3.1 | GO:0032771 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of transforming growth factor beta2 production(GO:0032912) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
1.0 | 1.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
1.0 | 11.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.0 | 4.1 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
1.0 | 8.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
1.0 | 6.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.0 | 2.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
1.0 | 11.3 | GO:0033260 | nuclear DNA replication(GO:0033260) |
1.0 | 3.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.0 | 11.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.0 | 4.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
1.0 | 2.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
1.0 | 3.0 | GO:0032765 | lymphotoxin A production(GO:0032641) regulation of mast cell cytokine production(GO:0032763) positive regulation of mast cell cytokine production(GO:0032765) lymphotoxin A biosynthetic process(GO:0042109) |
1.0 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
1.0 | 3.0 | GO:0051458 | corticotropin secretion(GO:0051458) |
1.0 | 10.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
1.0 | 20.1 | GO:0097421 | liver regeneration(GO:0097421) |
1.0 | 2.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.0 | 3.0 | GO:0051685 | maintenance of ER location(GO:0051685) |
1.0 | 3.0 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
1.0 | 5.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.0 | 3.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.0 | 4.9 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
1.0 | 9.8 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
1.0 | 2.9 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
1.0 | 60.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
1.0 | 9.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
1.0 | 5.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
1.0 | 43.7 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
1.0 | 9.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.0 | 1.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
1.0 | 16.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.0 | 1.9 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
1.0 | 9.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.0 | 1.9 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
1.0 | 2.9 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.0 | 42.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
1.0 | 11.4 | GO:0002021 | response to dietary excess(GO:0002021) |
1.0 | 23.8 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
1.0 | 13.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.9 | 0.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.9 | 28.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.9 | 2.8 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.9 | 4.7 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.9 | 5.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.9 | 5.6 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.9 | 8.5 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.9 | 0.9 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.9 | 3.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.9 | 0.9 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.9 | 1.9 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
0.9 | 2.8 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.9 | 2.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.9 | 4.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.9 | 0.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.9 | 71.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.9 | 18.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.9 | 5.4 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.9 | 4.5 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.9 | 5.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.9 | 2.7 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.9 | 6.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.9 | 1.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.9 | 6.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.9 | 3.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.9 | 1.8 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.9 | 2.6 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.9 | 1.8 | GO:0015866 | ADP transport(GO:0015866) ATP transport(GO:0015867) adenine nucleotide transport(GO:0051503) |
0.9 | 2.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.9 | 5.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.9 | 6.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.9 | 2.6 | GO:0035938 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.9 | 27.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.9 | 32.2 | GO:0043039 | amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.9 | 2.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.9 | 2.6 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.9 | 0.9 | GO:0021539 | subthalamus development(GO:0021539) |
0.9 | 2.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.9 | 3.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.8 | 0.8 | GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
0.8 | 0.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.8 | 5.9 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.8 | 3.4 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.8 | 0.8 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.8 | 5.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.8 | 8.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.8 | 11.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.8 | 2.5 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.8 | 23.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 7.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.8 | 4.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.8 | 9.9 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.8 | 0.8 | GO:0061511 | centriole elongation(GO:0061511) |
0.8 | 4.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.8 | 8.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.8 | 5.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.8 | 26.6 | GO:0031100 | organ regeneration(GO:0031100) |
0.8 | 1.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.8 | 3.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.8 | 6.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.8 | 1.6 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.8 | 1.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.8 | 6.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.8 | 3.2 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.8 | 2.4 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.8 | 5.5 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.8 | 3.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.8 | 0.8 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.8 | 2.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.8 | 14.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.8 | 2.3 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.8 | 11.6 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.8 | 3.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.8 | 2.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.8 | 1.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.8 | 0.8 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.8 | 2.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.8 | 4.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.8 | 6.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.8 | 36.4 | GO:0008033 | tRNA processing(GO:0008033) |
0.8 | 3.8 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.8 | 3.0 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.8 | 1.5 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.8 | 2.3 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.8 | 1.5 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
0.7 | 2.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 0.7 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.7 | 1.5 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.7 | 0.7 | GO:0033080 | immature T cell proliferation(GO:0033079) immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.7 | 2.2 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.7 | 1.5 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.7 | 2.2 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.7 | 5.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.7 | 3.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.7 | 1.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.7 | 5.2 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.7 | 1.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.7 | 2.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.7 | 6.6 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.7 | 6.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.7 | 71.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.7 | 2.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.7 | 1.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.7 | 3.6 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.7 | 1.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.7 | 1.5 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.7 | 13.0 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.7 | 1.4 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
0.7 | 51.2 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.7 | 9.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.7 | 1.4 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.7 | 2.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.7 | 5.8 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.7 | 0.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.7 | 0.7 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.7 | 2.1 | GO:0090671 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.7 | 1.4 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.7 | 2.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.7 | 0.7 | GO:0043335 | protein unfolding(GO:0043335) |
0.7 | 3.5 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.7 | 1.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.7 | 0.7 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.7 | 2.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.7 | 8.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.7 | 0.7 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.7 | 0.7 | GO:2000302 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.7 | 8.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.7 | 2.0 | GO:0051794 | catagen(GO:0042637) regulation of catagen(GO:0051794) |
0.7 | 2.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.7 | 6.6 | GO:0030647 | aminoglycoside antibiotic metabolic process(GO:0030647) |
0.7 | 14.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.7 | 3.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.7 | 5.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.7 | 1.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 1.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.7 | 0.7 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.7 | 2.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.7 | 2.0 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.6 | 12.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.6 | 3.2 | GO:1901299 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.6 | 3.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.6 | 6.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.6 | 1.3 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.6 | 17.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.6 | 3.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.6 | 13.3 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.6 | 2.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 16.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.6 | 3.1 | GO:0045006 | DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
0.6 | 6.3 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.6 | 2.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.6 | 8.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.6 | 13.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.6 | 0.6 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.6 | 2.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.6 | 12.7 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.6 | 1.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.6 | 1.8 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.6 | 1.2 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.6 | 3.6 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.6 | 2.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.6 | 1.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.6 | 1.2 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.6 | 13.6 | GO:0015893 | drug transport(GO:0015893) |
0.6 | 4.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.6 | 0.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.6 | 1.8 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.6 | 10.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.6 | 1.8 | GO:0035377 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.6 | 1.2 | GO:0050893 | sensory processing(GO:0050893) |
0.6 | 2.9 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.6 | 0.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.6 | 1.7 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
0.6 | 2.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.6 | 2.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.6 | 1.7 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.6 | 0.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.6 | 2.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 31.2 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.6 | 0.6 | GO:0000050 | urea cycle(GO:0000050) |
0.6 | 2.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.6 | 1.7 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.6 | 1.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.6 | 1.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.6 | 3.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.6 | 2.2 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.6 | 22.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.6 | 2.2 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.6 | 1.7 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.6 | 0.6 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.6 | 1.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 11.6 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.6 | 1.7 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.5 | 3.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 1.6 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.5 | 2.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.5 | 1.6 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.5 | 0.5 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.5 | 2.2 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.5 | 4.3 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.5 | 1.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.5 | 3.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 3.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 2.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.5 | 7.3 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.5 | 1.0 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.5 | 5.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.5 | 8.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.5 | 1.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 1.5 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.5 | 1.0 | GO:0007135 | meiosis II(GO:0007135) |
0.5 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.5 | 6.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.5 | 3.0 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.5 | 2.0 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.5 | 2.0 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.5 | 6.5 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.5 | 9.0 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.5 | 8.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.5 | 0.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 7.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.5 | 2.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.5 | 2.0 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.5 | 2.9 | GO:0042407 | cristae formation(GO:0042407) |
0.5 | 1.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.5 | 5.3 | GO:0007051 | spindle organization(GO:0007051) |
0.5 | 2.4 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.5 | 0.5 | GO:0010039 | response to iron ion(GO:0010039) |
0.5 | 0.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 1.9 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.5 | 1.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.5 | 3.3 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
0.5 | 9.9 | GO:0006414 | translational elongation(GO:0006414) |
0.5 | 1.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 1.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 0.9 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.5 | 1.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 1.4 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.5 | 0.9 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.5 | 8.7 | GO:0051031 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.5 | 3.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.5 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.5 | 1.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 1.3 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.4 | 3.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.4 | 10.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.9 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.4 | 1.8 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.4 | 0.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.4 | 4.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.4 | 13.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.4 | 5.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.4 | 0.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 3.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.4 | 3.5 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.4 | 4.8 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.4 | 2.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 2.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.4 | 1.7 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
0.4 | 0.4 | GO:0042726 | riboflavin metabolic process(GO:0006771) flavin-containing compound metabolic process(GO:0042726) |
0.4 | 0.4 | GO:0061074 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
0.4 | 2.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 0.4 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.4 | 0.4 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.4 | 1.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.4 | 3.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.7 | GO:1905225 | thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) response to thyrotropin-releasing hormone(GO:1905225) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.4 | 0.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.4 | 3.3 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.4 | 1.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.4 | 0.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.4 | 1.2 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.4 | 19.0 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.4 | 0.8 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.4 | 3.6 | GO:0009651 | response to salt stress(GO:0009651) |
0.4 | 0.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.4 | 0.4 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.4 | 1.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 0.4 | GO:0002839 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.4 | 6.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.4 | 1.6 | GO:1904179 | positive regulation of cardiac conduction(GO:1903781) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) positive regulation of adipose tissue development(GO:1904179) positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.4 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.4 | 0.4 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.4 | 2.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 1.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 1.5 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
0.4 | 1.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 0.7 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.4 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 2.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 0.4 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
0.4 | 0.4 | GO:1990776 | response to angiotensin(GO:1990776) |
0.4 | 0.7 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 0.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.4 | 1.4 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.4 | 0.4 | GO:0002720 | positive regulation of cytokine production involved in immune response(GO:0002720) |
0.4 | 0.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 2.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.4 | 1.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.4 | 0.4 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.4 | 1.8 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.4 | 4.6 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.4 | 1.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.4 | 2.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 0.7 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 0.7 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.3 | 14.5 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.3 | 0.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.3 | 0.3 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.3 | 0.7 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 1.0 | GO:1902893 | regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) |
0.3 | 1.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.3 | 4.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.3 | 2.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 7.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 1.3 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.3 | 0.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 3.3 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.3 | 1.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 0.7 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.3 | 0.3 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.3 | 2.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 1.3 | GO:1990834 | response to odorant(GO:1990834) |
0.3 | 1.6 | GO:0021764 | amygdala development(GO:0021764) |
0.3 | 1.9 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 16.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.3 | 1.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 2.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.3 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 3.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 1.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 5.7 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 3.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.3 | 0.6 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.3 | 0.6 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.3 | 2.2 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.3 | 2.8 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.3 | 0.6 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 5.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 4.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 2.1 | GO:0032445 | fructose transport(GO:0015755) fructose import(GO:0032445) cellular response to fructose stimulus(GO:0071332) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.3 | 3.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.3 | 1.2 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.3 | 0.6 | GO:0034982 | protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
0.3 | 1.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 1.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.3 | 1.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.3 | 1.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.3 | 0.6 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.3 | 2.3 | GO:1902583 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.3 | 0.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 1.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 4.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 1.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.3 | 0.8 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.3 | 1.4 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.3 | 1.4 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.3 | 1.6 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.3 | 0.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.3 | 3.8 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.3 | 0.8 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.3 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 0.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.3 | 1.9 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.3 | 2.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 2.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 2.6 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.3 | 0.5 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 1.3 | GO:0048743 | regulation of skeletal muscle fiber development(GO:0048742) positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 9.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.3 | 2.3 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) mast cell degranulation(GO:0043303) |
0.3 | 1.3 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.2 | 2.2 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.2 | 0.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 3.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.7 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 3.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 4.3 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.2 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 1.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 1.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 1.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.2 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.2 | 0.7 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.2 | 1.6 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.2 | 0.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 1.3 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.2 | 0.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.4 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.2 | 13.1 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.2 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.6 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.2 | 8.3 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.2 | 14.6 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.2 | 3.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.6 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 0.6 | GO:0061056 | sclerotome development(GO:0061056) |
0.2 | 2.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 2.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.6 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.2 | 3.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 0.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.2 | 0.2 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.2 | 1.8 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.2 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 1.0 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.2 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.4 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.2 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.8 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.2 | 0.4 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 0.6 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 3.9 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.2 | 0.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.2 | 0.4 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.2 | 1.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 0.6 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.2 | 3.8 | GO:0016575 | histone deacetylation(GO:0016575) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.6 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.2 | 1.9 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 8.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 2.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 1.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.2 | 10.1 | GO:0034728 | nucleosome organization(GO:0034728) |
0.2 | 0.5 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.2 | 7.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.2 | 0.5 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.2 | 0.7 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 2.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.2 | 0.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 2.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.7 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.2 | 1.3 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 1.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 2.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 0.5 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.2 | 0.6 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.9 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.2 | 0.2 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.6 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.2 | 0.5 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 0.2 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.2 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 1.5 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 1.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.7 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 12.9 | GO:0070268 | cornification(GO:0070268) |
0.1 | 6.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.6 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.1 | 0.7 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 0.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.3 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.1 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.5 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 1.8 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 1.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.5 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.1 | 0.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.9 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.5 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.1 | 0.5 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.1 | 0.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 1.3 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 1.4 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.1 | 0.9 | GO:0017145 | stem cell division(GO:0017145) |
0.1 | 0.1 | GO:0045471 | response to ethanol(GO:0045471) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.1 | 0.7 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.2 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.1 | 3.4 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.1 | 0.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.7 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.9 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 1.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 0.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.2 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 2.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 1.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.2 | GO:1900005 | regulation of serine-type endopeptidase activity(GO:1900003) positive regulation of serine-type endopeptidase activity(GO:1900005) regulation of serine-type peptidase activity(GO:1902571) positive regulation of serine-type peptidase activity(GO:1902573) |
0.1 | 0.4 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.1 | 0.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.6 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.1 | GO:0019860 | uracil metabolic process(GO:0019860) |
0.1 | 17.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 2.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 2.7 | GO:0021510 | spinal cord development(GO:0021510) |
0.1 | 1.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.1 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.1 | 0.2 | GO:0072576 | liver morphogenesis(GO:0072576) |
0.1 | 0.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.6 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 1.0 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.1 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
0.1 | 1.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 0.2 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.2 | GO:0042176 | regulation of protein catabolic process(GO:0042176) |
0.1 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 1.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 0.2 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.7 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 1.3 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0090342 | regulation of cell aging(GO:0090342) |
0.1 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.1 | 0.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.2 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.9 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.3 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.1 | GO:0021891 | olfactory bulb interneuron differentiation(GO:0021889) olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.0 | GO:0014032 | neural crest cell development(GO:0014032) |
0.0 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.2 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.0 | 0.2 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.6 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.3 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.1 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.0 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.0 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.0 | 0.0 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.0 | 0.0 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:2001275 | regulation of glucose import in response to insulin stimulus(GO:2001273) positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.2 | 64.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
13.9 | 13.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
13.4 | 66.8 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
13.3 | 80.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
10.2 | 51.2 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
9.9 | 79.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
9.5 | 28.6 | GO:0031523 | Myb complex(GO:0031523) |
8.7 | 86.6 | GO:0000796 | condensin complex(GO:0000796) |
8.6 | 25.8 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
8.5 | 33.8 | GO:0032301 | MutSalpha complex(GO:0032301) |
8.0 | 32.1 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
7.5 | 75.4 | GO:0097255 | R2TP complex(GO:0097255) |
7.3 | 95.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
7.1 | 42.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
7.1 | 28.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
7.0 | 21.0 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
6.9 | 68.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
6.7 | 20.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
6.6 | 26.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
6.5 | 51.7 | GO:0042382 | paraspeckles(GO:0042382) |
6.3 | 50.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
6.1 | 18.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
6.1 | 24.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
5.9 | 17.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
5.9 | 35.5 | GO:0001740 | Barr body(GO:0001740) |
5.7 | 22.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
5.6 | 16.9 | GO:0034455 | t-UTP complex(GO:0034455) |
5.6 | 27.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
5.4 | 70.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
5.3 | 21.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
5.3 | 32.0 | GO:0071817 | MMXD complex(GO:0071817) |
5.3 | 21.2 | GO:0055087 | Ski complex(GO:0055087) |
5.3 | 84.7 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
5.3 | 26.3 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
5.2 | 36.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
5.0 | 20.0 | GO:0070985 | TFIIK complex(GO:0070985) |
5.0 | 34.9 | GO:0031415 | NatA complex(GO:0031415) |
5.0 | 14.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
5.0 | 24.8 | GO:0032021 | NELF complex(GO:0032021) |
5.0 | 14.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
4.9 | 49.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
4.8 | 28.6 | GO:0090661 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
4.7 | 42.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
4.6 | 18.4 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
4.6 | 36.6 | GO:0070552 | BRISC complex(GO:0070552) |
4.5 | 22.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
4.4 | 80.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
4.4 | 17.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
4.4 | 21.8 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
4.3 | 21.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
4.2 | 21.1 | GO:0071797 | LUBAC complex(GO:0071797) |
4.1 | 12.4 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
4.1 | 53.8 | GO:0042555 | MCM complex(GO:0042555) |
4.1 | 32.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
4.0 | 48.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
3.9 | 19.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
3.9 | 19.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
3.8 | 19.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
3.8 | 65.0 | GO:0034709 | methylosome(GO:0034709) |
3.8 | 11.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
3.7 | 140.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
3.6 | 76.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
3.6 | 36.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
3.6 | 97.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
3.6 | 25.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
3.6 | 39.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
3.6 | 17.8 | GO:0097422 | tubular endosome(GO:0097422) |
3.6 | 42.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
3.4 | 27.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
3.4 | 10.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
3.4 | 30.7 | GO:0005638 | lamin filament(GO:0005638) |
3.4 | 20.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
3.3 | 10.0 | GO:0044393 | microspike(GO:0044393) |
3.3 | 16.3 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
3.3 | 32.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
3.2 | 32.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
3.2 | 16.1 | GO:0033503 | HULC complex(GO:0033503) |
3.2 | 29.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
3.2 | 15.9 | GO:0016589 | NURF complex(GO:0016589) |
3.2 | 15.8 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
3.1 | 33.9 | GO:0005688 | U6 snRNP(GO:0005688) |
3.0 | 93.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
3.0 | 6.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
3.0 | 39.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
3.0 | 44.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
3.0 | 11.9 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
3.0 | 68.3 | GO:0071564 | npBAF complex(GO:0071564) |
3.0 | 20.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
2.9 | 5.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
2.9 | 17.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
2.9 | 8.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
2.9 | 34.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
2.8 | 31.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
2.8 | 22.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
2.8 | 13.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.8 | 11.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
2.7 | 22.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
2.7 | 30.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
2.7 | 78.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
2.7 | 8.0 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
2.7 | 50.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
2.7 | 16.0 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
2.7 | 42.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
2.7 | 5.3 | GO:0071010 | prespliceosome(GO:0071010) |
2.6 | 2.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
2.6 | 10.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
2.6 | 13.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
2.6 | 5.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.5 | 27.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
2.5 | 7.5 | GO:0005715 | late recombination nodule(GO:0005715) |
2.5 | 5.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
2.5 | 34.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
2.5 | 7.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
2.5 | 46.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
2.4 | 26.6 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
2.4 | 137.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
2.4 | 57.5 | GO:0005861 | troponin complex(GO:0005861) |
2.4 | 7.1 | GO:0071159 | NF-kappaB complex(GO:0071159) |
2.4 | 7.1 | GO:0018444 | translation release factor complex(GO:0018444) |
2.4 | 21.3 | GO:0032039 | integrator complex(GO:0032039) |
2.4 | 9.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
2.3 | 51.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
2.3 | 11.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
2.3 | 2.3 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
2.3 | 4.6 | GO:0031213 | RSF complex(GO:0031213) |
2.3 | 11.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
2.3 | 25.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
2.3 | 25.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
2.3 | 24.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
2.2 | 24.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
2.2 | 11.1 | GO:0070470 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
2.2 | 19.8 | GO:0005642 | annulate lamellae(GO:0005642) |
2.2 | 8.7 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
2.2 | 10.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
2.1 | 10.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
2.1 | 35.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
2.1 | 8.4 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
2.1 | 18.7 | GO:0005819 | spindle(GO:0005819) |
2.1 | 2.1 | GO:0030677 | ribonuclease P complex(GO:0030677) |
2.1 | 4.1 | GO:0043198 | dendritic shaft(GO:0043198) |
2.0 | 16.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
2.0 | 22.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
2.0 | 47.7 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
1.9 | 90.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.9 | 36.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.9 | 30.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.9 | 5.8 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
1.9 | 21.0 | GO:0016600 | flotillin complex(GO:0016600) |
1.9 | 60.7 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
1.9 | 206.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
1.9 | 26.3 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
1.8 | 22.2 | GO:0090543 | Flemming body(GO:0090543) |
1.8 | 18.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.8 | 11.0 | GO:0001520 | outer dense fiber(GO:0001520) |
1.8 | 11.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.8 | 7.3 | GO:0035061 | interchromatin granule(GO:0035061) |
1.8 | 9.1 | GO:0071986 | Ragulator complex(GO:0071986) |
1.8 | 7.2 | GO:1990357 | terminal web(GO:1990357) |
1.8 | 21.7 | GO:0090544 | BAF-type complex(GO:0090544) |
1.7 | 17.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.7 | 5.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.7 | 8.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.7 | 11.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
1.7 | 10.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.6 | 1.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.6 | 32.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.6 | 19.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.6 | 15.9 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.6 | 6.3 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
1.6 | 6.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.6 | 18.7 | GO:0030008 | TRAPP complex(GO:0030008) |
1.5 | 10.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.5 | 9.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.5 | 56.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.5 | 4.5 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
1.5 | 6.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.5 | 16.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
1.5 | 13.4 | GO:0070652 | HAUS complex(GO:0070652) |
1.5 | 11.7 | GO:0000322 | storage vacuole(GO:0000322) |
1.4 | 10.1 | GO:0016272 | prefoldin complex(GO:0016272) |
1.4 | 31.8 | GO:1990391 | DNA repair complex(GO:1990391) |
1.4 | 4.3 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
1.4 | 12.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.4 | 14.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.4 | 2.8 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
1.4 | 5.6 | GO:0001940 | male pronucleus(GO:0001940) |
1.4 | 4.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
1.4 | 115.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
1.3 | 9.4 | GO:0016363 | nuclear matrix(GO:0016363) |
1.3 | 6.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.3 | 11.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
1.3 | 29.3 | GO:0032156 | septin cytoskeleton(GO:0032156) |
1.3 | 7.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.3 | 1.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.2 | 80.8 | GO:0005643 | nuclear pore(GO:0005643) |
1.2 | 130.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.2 | 55.5 | GO:0005844 | polysome(GO:0005844) |
1.2 | 3.7 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
1.2 | 4.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.2 | 24.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.2 | 3.6 | GO:0097441 | basilar dendrite(GO:0097441) |
1.2 | 8.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.2 | 9.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.2 | 7.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.2 | 40.9 | GO:0000502 | proteasome complex(GO:0000502) |
1.2 | 3.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.2 | 12.7 | GO:0000346 | transcription export complex(GO:0000346) |
1.2 | 26.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.2 | 2.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.1 | 4.6 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
1.1 | 7.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.1 | 43.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.1 | 7.7 | GO:0070938 | contractile ring(GO:0070938) |
1.1 | 6.6 | GO:0005685 | U1 snRNP(GO:0005685) |
1.1 | 2.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.1 | 4.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
1.1 | 8.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.1 | 11.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.1 | 6.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.1 | 1.1 | GO:0097342 | ripoptosome(GO:0097342) |
1.0 | 12.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.0 | 74.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.0 | 28.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.0 | 5.2 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
1.0 | 4.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
1.0 | 19.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
1.0 | 1.0 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
1.0 | 12.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.0 | 10.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.0 | 11.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.0 | 17.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.0 | 6.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.9 | 0.9 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.9 | 2.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.9 | 14.0 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.9 | 3.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.9 | 7.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.9 | 4.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.9 | 1.8 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.9 | 9.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.9 | 3.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.9 | 9.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.9 | 45.8 | GO:0000793 | condensed chromosome(GO:0000793) |
0.9 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.9 | 4.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.9 | 6.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.9 | 24.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.9 | 9.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.8 | 18.5 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.8 | 12.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.8 | 8.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.8 | 8.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.8 | 48.1 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.8 | 4.1 | GO:0030894 | replisome(GO:0030894) nuclear replisome(GO:0043601) |
0.8 | 11.5 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.8 | 5.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.8 | 14.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.8 | 20.6 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.8 | 9.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.8 | 12.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.8 | 35.0 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.8 | 34.8 | GO:0045095 | keratin filament(GO:0045095) |
0.8 | 10.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.8 | 3.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.8 | 64.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.8 | 4.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.7 | 4.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.7 | 4.4 | GO:0097346 | INO80-type complex(GO:0097346) |
0.7 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.7 | 3.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.7 | 7.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.7 | 0.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.7 | 10.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.7 | 21.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.7 | 5.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 3.3 | GO:0032449 | CBM complex(GO:0032449) |
0.7 | 5.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.7 | 4.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.7 | 2.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.7 | 12.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 5.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 11.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.6 | 188.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.6 | 73.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.6 | 3.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 2.5 | GO:0032044 | DSIF complex(GO:0032044) |
0.6 | 3.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.6 | 1.8 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.6 | 1.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.6 | 7.9 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.6 | 1.8 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.6 | 2.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 4.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.6 | 6.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.6 | 1.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.6 | 68.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.5 | 0.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.5 | 12.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 1.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 2.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.5 | 12.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 3.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 42.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 5.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 3.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 7.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 33.8 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 8.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.5 | 1.9 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.5 | 5.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.5 | 1.4 | GO:0044305 | calyx of Held(GO:0044305) |
0.5 | 2.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 21.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 1.3 | GO:0001652 | granular component(GO:0001652) |
0.4 | 11.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.4 | 1.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 13.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 3.3 | GO:0032059 | bleb(GO:0032059) |
0.4 | 12.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 2.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 2.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 3.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 2.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.4 | 9.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 32.4 | GO:0016605 | PML body(GO:0016605) |
0.4 | 2.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.4 | 25.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 1.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 0.4 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 6.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 24.8 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 2.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 2.3 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.3 | 3.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.9 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 798.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 1.5 | GO:0044754 | autolysosome(GO:0044754) |
0.3 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 1.2 | GO:0042589 | zymogen granule(GO:0042588) zymogen granule membrane(GO:0042589) |
0.3 | 10.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 23.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) organelle outer membrane(GO:0031968) |
0.3 | 1.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 5.7 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.5 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 0.5 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 1.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 5.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 6.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 4.0 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 6.4 | GO:0043034 | costamere(GO:0043034) |
0.2 | 3.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 5.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 8.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 1.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 2.8 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 1.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 1.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 3.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 0.9 | GO:0044309 | neuron spine(GO:0044309) |
0.2 | 8.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 4.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 40.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 6.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 1.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.7 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 7.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 1.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.2 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 1.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.1 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 2.4 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.1 | 0.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 3.0 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 0.3 | GO:0031906 | late endosome lumen(GO:0031906) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.0 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.7 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 1.0 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.0 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0098536 | deuterosome(GO:0098536) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.4 | 117.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
20.7 | 62.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
15.7 | 62.8 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
13.8 | 55.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
13.4 | 67.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
13.3 | 53.1 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
13.2 | 52.7 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
13.0 | 91.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
10.7 | 74.6 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
10.4 | 41.5 | GO:0004998 | transferrin receptor activity(GO:0004998) |
10.3 | 93.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
9.5 | 28.5 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
9.1 | 27.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
9.0 | 36.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
9.0 | 53.8 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
8.5 | 33.8 | GO:0032143 | single thymine insertion binding(GO:0032143) |
8.0 | 16.0 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
7.9 | 23.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
7.1 | 28.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
7.0 | 34.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
6.9 | 34.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
6.9 | 68.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
6.8 | 27.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
6.8 | 40.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
6.8 | 47.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
6.7 | 33.6 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
6.7 | 20.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
6.6 | 26.3 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
6.6 | 26.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
6.2 | 6.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
6.2 | 18.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
6.0 | 24.0 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
5.9 | 35.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
5.9 | 23.6 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
5.8 | 46.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
5.8 | 17.4 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
5.6 | 16.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
5.6 | 28.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
5.5 | 16.6 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
5.5 | 49.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
5.4 | 16.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
5.4 | 5.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
5.4 | 21.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
5.3 | 32.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
5.3 | 16.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
5.3 | 16.0 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
5.3 | 15.8 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
5.2 | 15.6 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
5.2 | 15.5 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
5.1 | 20.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
5.1 | 46.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
5.0 | 29.8 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
5.0 | 14.9 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
4.9 | 29.5 | GO:0051870 | methotrexate binding(GO:0051870) |
4.9 | 59.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
4.9 | 19.4 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
4.8 | 38.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
4.8 | 28.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
4.8 | 95.6 | GO:0070628 | proteasome binding(GO:0070628) |
4.7 | 226.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
4.7 | 23.4 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
4.6 | 32.5 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
4.6 | 18.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
4.5 | 13.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
4.4 | 80.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
4.4 | 13.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
4.4 | 17.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
4.4 | 13.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
4.4 | 48.6 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
4.3 | 25.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
4.3 | 4.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
4.2 | 17.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
4.2 | 12.7 | GO:0015141 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) succinate transmembrane transporter activity(GO:0015141) |
4.2 | 16.9 | GO:0038025 | reelin receptor activity(GO:0038025) |
4.2 | 58.8 | GO:0031014 | troponin T binding(GO:0031014) |
4.1 | 20.6 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
4.1 | 32.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
4.1 | 36.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
4.0 | 24.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
4.0 | 19.9 | GO:0016403 | dimethylargininase activity(GO:0016403) |
4.0 | 11.9 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
3.9 | 11.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
3.9 | 34.7 | GO:0015288 | porin activity(GO:0015288) |
3.8 | 42.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
3.8 | 53.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
3.8 | 64.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
3.7 | 11.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
3.7 | 11.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
3.6 | 10.9 | GO:0036033 | mediator complex binding(GO:0036033) |
3.6 | 29.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
3.6 | 25.0 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
3.6 | 10.7 | GO:0004797 | thymidine kinase activity(GO:0004797) |
3.6 | 32.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
3.5 | 7.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
3.5 | 10.6 | GO:0004766 | spermidine synthase activity(GO:0004766) |
3.5 | 10.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
3.5 | 10.5 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
3.5 | 10.4 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
3.4 | 20.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
3.4 | 10.2 | GO:0030984 | kininogen binding(GO:0030984) |
3.4 | 13.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
3.4 | 10.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
3.4 | 20.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
3.3 | 16.7 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
3.3 | 16.7 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
3.3 | 59.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
3.3 | 13.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
3.3 | 29.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
3.3 | 19.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
3.2 | 13.0 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
3.2 | 16.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
3.2 | 9.7 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
3.2 | 16.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
3.2 | 25.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.2 | 34.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
3.1 | 133.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
3.1 | 9.3 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
3.0 | 6.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
3.0 | 24.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
3.0 | 9.0 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
3.0 | 23.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
3.0 | 3.0 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
2.9 | 11.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
2.9 | 23.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
2.9 | 8.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.9 | 11.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
2.9 | 11.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.8 | 85.5 | GO:0008143 | poly(A) binding(GO:0008143) |
2.8 | 60.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
2.7 | 11.0 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
2.7 | 11.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
2.7 | 68.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
2.7 | 30.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.7 | 30.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
2.7 | 2.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
2.7 | 8.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
2.7 | 78.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
2.7 | 80.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
2.7 | 8.0 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
2.7 | 90.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
2.6 | 26.4 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
2.6 | 68.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
2.6 | 7.9 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.6 | 5.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.6 | 67.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
2.6 | 18.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
2.6 | 12.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
2.6 | 2.6 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
2.5 | 5.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
2.5 | 45.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
2.5 | 30.5 | GO:0031386 | protein tag(GO:0031386) |
2.5 | 25.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
2.5 | 10.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.5 | 7.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
2.5 | 5.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
2.5 | 7.5 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
2.5 | 20.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.5 | 12.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.5 | 32.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
2.4 | 19.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
2.4 | 7.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.4 | 38.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
2.4 | 7.3 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
2.4 | 14.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
2.4 | 71.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
2.4 | 4.8 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
2.3 | 14.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.3 | 25.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.3 | 18.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.3 | 23.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
2.3 | 2.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
2.3 | 4.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.3 | 9.0 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
2.2 | 46.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
2.2 | 17.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
2.2 | 2.2 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
2.2 | 30.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
2.2 | 4.4 | GO:0003998 | acylphosphatase activity(GO:0003998) |
2.2 | 39.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
2.2 | 2.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
2.2 | 21.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
2.1 | 2.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
2.1 | 19.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
2.1 | 8.5 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
2.1 | 12.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
2.1 | 35.8 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
2.1 | 2.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.1 | 35.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.1 | 49.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
2.1 | 16.5 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
2.1 | 2.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
2.1 | 8.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
2.0 | 10.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
2.0 | 6.1 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
2.0 | 58.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
2.0 | 22.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.0 | 20.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
2.0 | 6.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
2.0 | 5.9 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
2.0 | 37.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
2.0 | 2.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
2.0 | 25.4 | GO:0000339 | RNA cap binding(GO:0000339) |
1.9 | 5.8 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
1.9 | 23.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.9 | 15.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.9 | 3.8 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
1.9 | 19.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
1.9 | 17.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.9 | 9.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
1.9 | 9.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.9 | 14.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.8 | 36.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.8 | 12.8 | GO:0050733 | RS domain binding(GO:0050733) |
1.8 | 3.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.8 | 10.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.8 | 46.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.8 | 8.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.8 | 5.3 | GO:0035173 | histone kinase activity(GO:0035173) |
1.8 | 24.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.8 | 14.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.8 | 33.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.8 | 15.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.7 | 3.5 | GO:0070538 | oleic acid binding(GO:0070538) |
1.7 | 6.9 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.7 | 3.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.7 | 6.9 | GO:0016531 | copper chaperone activity(GO:0016531) |
1.7 | 8.6 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
1.7 | 10.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.7 | 236.4 | GO:0042393 | histone binding(GO:0042393) |
1.7 | 6.8 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
1.7 | 8.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.7 | 10.2 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
1.7 | 20.3 | GO:0089720 | caspase binding(GO:0089720) |
1.7 | 10.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.7 | 362.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.7 | 5.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.7 | 58.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.7 | 13.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.6 | 16.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.6 | 6.5 | GO:0004335 | galactokinase activity(GO:0004335) |
1.6 | 24.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.6 | 8.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
1.6 | 1.6 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
1.6 | 123.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.6 | 35.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.6 | 4.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.6 | 18.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.6 | 4.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.5 | 1.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
1.5 | 12.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.5 | 4.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.5 | 10.6 | GO:0005497 | androgen binding(GO:0005497) |
1.5 | 18.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
1.5 | 6.1 | GO:0043515 | kinetochore binding(GO:0043515) |
1.5 | 6.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.5 | 4.5 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
1.5 | 38.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.5 | 4.5 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
1.5 | 4.4 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
1.5 | 41.5 | GO:0005123 | death receptor binding(GO:0005123) |
1.5 | 16.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.5 | 2.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
1.5 | 5.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.5 | 5.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
1.5 | 4.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.5 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.4 | 4.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
1.4 | 7.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.4 | 4.3 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
1.4 | 5.7 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
1.4 | 11.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.4 | 4.3 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
1.4 | 17.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.4 | 8.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
1.4 | 7.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
1.4 | 8.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
1.4 | 2.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.4 | 12.5 | GO:0019213 | deacetylase activity(GO:0019213) |
1.4 | 8.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.4 | 2.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.4 | 8.2 | GO:0050692 | DBD domain binding(GO:0050692) |
1.4 | 6.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.3 | 4.0 | GO:0070984 | SET domain binding(GO:0070984) |
1.3 | 6.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.3 | 1.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
1.3 | 109.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
1.3 | 15.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
1.3 | 7.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.3 | 12.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.3 | 1.3 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
1.3 | 17.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.3 | 3.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
1.3 | 22.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.3 | 5.0 | GO:0032810 | sterol response element binding(GO:0032810) |
1.3 | 7.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
1.3 | 7.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
1.3 | 10.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.2 | 2.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.2 | 3.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.2 | 8.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
1.2 | 3.7 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
1.2 | 3.7 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
1.2 | 25.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.2 | 3.6 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
1.2 | 73.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.2 | 21.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.2 | 7.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
1.2 | 4.7 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
1.2 | 11.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.2 | 4.7 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
1.2 | 16.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.2 | 4.7 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
1.1 | 17.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.1 | 8.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.1 | 16.0 | GO:0070513 | death domain binding(GO:0070513) |
1.1 | 9.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.1 | 4.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.1 | 12.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.1 | 3.4 | GO:0048256 | flap endonuclease activity(GO:0048256) |
1.1 | 8.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.1 | 1.1 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.1 | 3.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
1.1 | 33.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.1 | 4.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.1 | 2.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
1.1 | 10.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.1 | 2.2 | GO:0000829 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.1 | 9.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.1 | 24.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
1.1 | 14.0 | GO:0031491 | nucleosome binding(GO:0031491) |
1.1 | 7.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.1 | 8.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.1 | 9.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.1 | 2.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.1 | 42.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
1.1 | 9.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.1 | 4.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
1.0 | 40.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.0 | 5.2 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
1.0 | 4.2 | GO:0015266 | protein channel activity(GO:0015266) |
1.0 | 9.3 | GO:0039706 | co-receptor binding(GO:0039706) |
1.0 | 3.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
1.0 | 3.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.0 | 11.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.0 | 6.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.0 | 3.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
1.0 | 33.7 | GO:0000049 | tRNA binding(GO:0000049) |
1.0 | 3.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.0 | 7.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.9 | 7.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.9 | 8.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.9 | 6.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.9 | 3.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.9 | 2.8 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.9 | 3.7 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.9 | 32.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.9 | 3.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.9 | 5.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.9 | 10.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.9 | 1.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.9 | 6.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.9 | 9.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.9 | 2.6 | GO:0052810 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.9 | 2.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.9 | 2.6 | GO:0086078 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
0.9 | 3.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.8 | 0.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.8 | 4.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.8 | 2.5 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.8 | 5.0 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.8 | 0.8 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.8 | 2.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.8 | 4.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.8 | 9.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 0.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.8 | 3.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.8 | 2.4 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.8 | 34.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.8 | 2.4 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.8 | 3.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.8 | 4.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.8 | 4.0 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.8 | 4.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.8 | 4.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.8 | 0.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.8 | 4.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.8 | 5.5 | GO:0042979 | ornithine decarboxylase activator activity(GO:0042978) ornithine decarboxylase regulator activity(GO:0042979) |
0.8 | 13.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.8 | 9.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.8 | 2.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 6.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.8 | 10.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.8 | 2.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 2.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.8 | 12.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.8 | 11.4 | GO:0032451 | demethylase activity(GO:0032451) |
0.8 | 2.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.7 | 0.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.7 | 2.2 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.7 | 5.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.7 | 3.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.7 | 2.2 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.7 | 0.7 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.7 | 9.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.7 | 2.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.7 | 29.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.7 | 2.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.7 | 5.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.7 | 13.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.7 | 7.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.7 | 1.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.7 | 2.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 14.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.7 | 2.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.7 | 3.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.7 | 2.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.7 | 4.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.7 | 38.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.7 | 3.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.7 | 31.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.7 | 4.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 22.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.7 | 5.2 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 30.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.6 | 5.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 1.9 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.6 | 4.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.6 | 10.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.6 | 10.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.6 | 8.9 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.6 | 2.5 | GO:0031208 | POZ domain binding(GO:0031208) |
0.6 | 47.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.6 | 1.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.6 | 2.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.6 | 2.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 7.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.6 | 9.7 | GO:0004386 | helicase activity(GO:0004386) |
0.6 | 3.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.6 | 5.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 3.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.6 | 21.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.6 | 2.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.6 | 0.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 1.8 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.6 | 15.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.6 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 1.8 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.6 | 0.6 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.6 | 55.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.6 | 2.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.6 | 2.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.6 | 0.6 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.6 | 23.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.6 | 2.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 5.0 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.6 | 1.7 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.6 | 2.8 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.6 | 1.7 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.6 | 7.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 1.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.5 | 11.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.5 | 9.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.5 | 12.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.5 | 13.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 1.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.5 | 2.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 1.6 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.5 | 6.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.5 | 1.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.5 | 1.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.5 | 33.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.5 | 1.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.5 | 0.5 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.5 | 5.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.5 | 1.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.5 | 4.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.5 | 0.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.5 | 35.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.5 | 23.6 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.5 | 35.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.5 | 0.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.5 | 6.8 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.5 | 3.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 1.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 2.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.5 | 7.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 3.3 | GO:0016829 | lyase activity(GO:0016829) |
0.5 | 5.2 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.5 | 4.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 530.5 | GO:0003723 | RNA binding(GO:0003723) |
0.5 | 1.4 | GO:0051287 | NAD binding(GO:0051287) |
0.5 | 4.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.5 | 1.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 9.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.5 | 0.5 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.5 | 1.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.5 | 1.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 1.4 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.5 | 3.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.5 | 1.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.5 | 0.9 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.5 | 0.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.5 | 3.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 3.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.4 | 0.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 2.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 3.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 11.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 1.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 2.1 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.4 | 1.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 13.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 1.7 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.4 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.4 | 2.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 4.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.4 | 9.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.4 | 1.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.4 | 2.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 1.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.4 | 4.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.4 | 1.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 2.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 1.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.4 | 2.6 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.4 | 3.3 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.4 | 1.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 7.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.4 | 0.4 | GO:0035276 | ethanol binding(GO:0035276) |
0.3 | 4.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 3.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 2.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.3 | 2.4 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.3 | 1.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 1.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.3 | 1.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 15.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 0.7 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.3 | 4.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 1.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 3.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.3 | 2.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 4.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 1.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 2.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 6.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 1.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 2.1 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.3 | 1.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 5.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 12.1 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.3 | 1.4 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 2.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 0.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 1.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.3 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 1.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 2.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 0.3 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.3 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 1.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 6.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 14.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 1.0 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.2 | 4.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 2.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 2.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 1.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 3.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 3.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 1.3 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 3.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 3.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 1.6 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 6.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 1.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.2 | 2.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 2.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 72.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 1.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 1.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 11.3 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.6 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 6.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 3.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 1.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 0.6 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 1.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.2 | 3.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 44.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 1.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 2.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 1.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.2 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 1.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.7 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.7 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.2 | 2.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 2.6 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.2 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 3.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.2 | 0.8 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 0.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.2 | GO:0072341 | modified amino acid binding(GO:0072341) |
0.2 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 3.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 2.6 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.2 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 1.6 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 3.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 2.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.8 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.5 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.1 | 0.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 1.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.5 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.1 | 1.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 6.6 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:0008144 | drug binding(GO:0008144) |
0.1 | 0.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 1.0 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 15.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 1.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) kinase inhibitor activity(GO:0019210) |
0.1 | 4.6 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 1.2 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 4.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.1 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
0.1 | 0.6 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 2.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 4.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 3.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.2 | GO:0034191 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 1.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 5.2 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 0.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.2 | GO:0015665 | choline transmembrane transporter activity(GO:0015220) alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.5 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.2 | GO:0034594 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.2 | 8.2 | PID IFNG PATHWAY | IFN-gamma pathway |
4.9 | 68.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
3.5 | 27.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
3.2 | 166.2 | PID BARD1 PATHWAY | BARD1 signaling events |
2.7 | 167.5 | PID PLK1 PATHWAY | PLK1 signaling events |
2.6 | 42.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
2.6 | 146.5 | PID AURORA B PATHWAY | Aurora B signaling |
2.5 | 268.0 | PID E2F PATHWAY | E2F transcription factor network |
2.4 | 100.2 | PID ATR PATHWAY | ATR signaling pathway |
2.3 | 42.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
2.3 | 4.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
2.3 | 65.7 | PID ATM PATHWAY | ATM pathway |
2.1 | 249.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.5 | 59.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.5 | 14.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.5 | 33.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.4 | 15.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.3 | 132.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.2 | 71.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.2 | 41.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.2 | 29.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.2 | 15.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.1 | 2.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.1 | 23.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.1 | 8.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.1 | 23.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.0 | 4.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.0 | 28.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.9 | 7.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 2.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 2.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.8 | 4.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.8 | 29.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 78.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.8 | 33.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.7 | 19.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.7 | 44.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.7 | 2.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.7 | 44.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.7 | 42.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 2.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.7 | 12.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.7 | 11.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 10.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.7 | 43.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.6 | 20.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.6 | 35.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 28.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.5 | 7.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 22.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.5 | 5.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 15.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 1.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 3.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.5 | 34.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 30.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 16.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 13.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 2.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 9.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 12.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 8.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 9.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 4.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 19.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 2.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 8.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 4.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 5.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 5.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 3.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 5.4 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 2.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 5.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 3.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 4.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.1 | 154.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
7.1 | 28.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
6.6 | 65.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
6.3 | 56.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
6.1 | 177.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
5.4 | 75.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
4.5 | 158.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
4.5 | 90.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
4.3 | 8.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
4.3 | 29.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
4.2 | 105.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
4.0 | 91.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
4.0 | 162.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
3.9 | 3.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
3.7 | 179.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
3.4 | 337.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
3.4 | 3.4 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
3.3 | 103.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
3.3 | 55.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
3.1 | 109.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
3.1 | 30.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
3.0 | 39.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
3.0 | 79.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
2.8 | 90.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
2.8 | 165.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
2.8 | 63.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
2.8 | 68.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.7 | 40.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
2.7 | 54.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
2.7 | 45.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
2.6 | 56.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
2.6 | 35.7 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
2.4 | 33.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
2.4 | 73.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
2.3 | 46.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
2.3 | 18.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
2.3 | 18.4 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
2.3 | 82.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
2.3 | 61.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.2 | 307.0 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
2.1 | 64.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
2.1 | 19.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
2.1 | 50.5 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
2.1 | 37.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
2.0 | 6.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
2.0 | 20.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
2.0 | 43.0 | REACTOME S PHASE | Genes involved in S Phase |
2.0 | 52.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
1.9 | 89.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
1.9 | 155.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.8 | 44.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
1.7 | 15.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
1.7 | 78.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
1.7 | 81.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.6 | 10.9 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.5 | 20.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.5 | 23.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.4 | 7.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
1.4 | 23.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.4 | 19.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.4 | 19.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.3 | 12.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.3 | 13.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
1.3 | 215.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.3 | 18.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.3 | 14.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.3 | 3.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.2 | 73.5 | REACTOME TRANSLATION | Genes involved in Translation |
1.2 | 20.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.2 | 9.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.2 | 2.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.1 | 42.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.1 | 19.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
1.1 | 44.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.1 | 36.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.0 | 15.3 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
1.0 | 6.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.0 | 28.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.0 | 66.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.0 | 18.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.0 | 52.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 41.0 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
1.0 | 17.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.9 | 62.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.9 | 1.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.9 | 11.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.9 | 14.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.9 | 32.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.9 | 12.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.9 | 3.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.9 | 16.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.8 | 10.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.8 | 15.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 26.9 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.8 | 26.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.8 | 10.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.8 | 119.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.8 | 52.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 12.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.7 | 0.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.7 | 62.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.7 | 4.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.7 | 11.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.7 | 3.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.7 | 0.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.6 | 11.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 7.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 8.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.6 | 5.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.6 | 11.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.6 | 12.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.6 | 14.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 8.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.6 | 6.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.6 | 9.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 14.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 10.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 1.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 14.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.5 | 22.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.5 | 4.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 69.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 12.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 7.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 9.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 7.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 14.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 10.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 6.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 3.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 14.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 1.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 2.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 5.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 8.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 10.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 3.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 3.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 5.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 3.8 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 7.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 2.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 2.3 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 3.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 2.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 10.3 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 3.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 2.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 14.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 4.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 4.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 3.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 1.8 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 3.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 2.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.2 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 5.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 2.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |